Literature DB >> 9425947

Screening for hepatocellular carcinoma.

J Collier1, M Sherman.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9425947     DOI： 10.1002/hep.510270140

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  86 in total

1.  Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.

Authors:  Fen-Yu Ren; Xi-Xu Piao; Ai-Lian Jin
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

Review 2.  [HCC screening].

Authors:  T Albrecht
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

Review 3.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

4.  A sub-centimeter HCC with bright loop appearance diagnosed by contrast-enhanced ultrasonography.

Authors:  Shuichi Sato; Tatsuya Miyake; Asako Fukuma; Eri Nitta; Noritsugu Yamashita; Takuya Hanaoka; Junichi Ishine; Hiroshi Tobita; Shuji Akagi; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Med Ultrason (2001)       Date:  2010-11-27       Impact factor: 1.314

5.  Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker.

Authors:  Jing Shen; Antai Wang; Qiao Wang; Irina Gurvich; Abby B Siegel; Helen Remotti; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-14       Impact factor: 4.254

6.  Non-invasive portography: a microbubble-induced three-dimensional sonogram for discriminating idiopathic portal hypertension from cirrhosis.

Authors:  H Maruyama; H Okugawa; S Kobayashi; H Yoshizumi; M Takahashi; H Ishibashi; O Yokosuka
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

7.  Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization.

Authors:  Takuma Arai; Akira Kobayashi; Ayumi Ohya; Masaaki Takahashi; Takahide Yokoyama; Akira Shimizu; Hiroaki Motoyama; Norihiko Furusawa; Tsuyoshi Notake; Noriyuki Kitagawa; Hiroshi Sakai; Hiroshi Imamura; Masumi Kadoya; Shin-Ichi Miyagawa
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402

8.  Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.

Authors:  L Benvegnù; M Gios; S Boccato; A Alberti
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.

Authors:  J Qi; J Wang; H Katayama; S Sen; S M Liu
Journal:  Neoplasma       Date:  2013       Impact factor: 2.575

Review 10.  Screening for hepatocellular carcinoma: why, when, how?

Authors:  Miguel R Arguedas
Journal:  Curr Gastroenterol Rep       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.